ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 75 filers reported holding ALBIREO PHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $313,000 | +26.7% | 11,847 | -21.7% | 0.00% | 0.0% |
| Q1 2020 | $247,000 | +50.6% | 15,128 | +197.4% | 0.00% | 0.0% |
| Q1 2019 | $164,000 | -9.9% | 5,087 | -31.4% | 0.00% | 0.0% |
| Q4 2018 | $182,000 | -35.2% | 7,413 | -12.9% | 0.00% | 0.0% |
| Q3 2018 | $281,000 | +70.3% | 8,513 | +83.3% | 0.00% | 0.0% |
| Q2 2018 | $165,000 | – | 4,645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |